Literature DB >> 12528512

[Protective effect of tanshinone on injured cultured PC12 cells in vitro].

L N He1, J Yang, Y Jiang, J Wang, C Liu, S B He.   

Abstract

OBJECTIVE: To investigate the protective effects of tanshinone on ischemia-like injury models.
METHOD: Six ischemia models including hypoxia, hypoglucose, oxidant injury, calcium overload, nitric oxide neurotoxicity and glutamic acid injury were used to assay the anti-ischemic roles of tanshinone in cultured PC12 cells, by using morphological examination, MTT staining and LDH measurement. RESULT: It was found that 3. 125-200 microliters.ml-1 tanshinone possessed obvious protective effects on PC12 cells from six ischemia-like injury models. Tanshinone could increase the number of life cells and decrease LDH activity significantly, particularly in hypoxia and caffeine injured model.
CONCLUSION: Tanshinone protected PC12 cells from all injury models effectively in vitro. Its action may mainly focus on inhibiting development of the primary period of ischemia injury and calcium overloading injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12528512

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

Review 1.  Insights into the monomers and single drugs of Chinese herbal medicine on myocardial preservation.

Authors:  Shi-Min Yuan; Hua Jing
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-12-30

2.  Tanshinone IIA reduces macrophage death induced by hydrogen peroxide by upregulating glutathione peroxidase.

Authors:  Yu-I Li; Gary Elmer; Renée C Leboeuf
Journal:  Life Sci       Date:  2008-08-16       Impact factor: 5.037

3.  Sulfotanshinone sodium injection for unstable angina pectoris: a systematic review of randomized controlled trials.

Authors:  Xuelan Qiu; Andrew Miles; Xuehua Jiang; Xin Sun; Nan Yang
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-04       Impact factor: 2.629

Review 4.  Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update.

Authors:  Roohi Mohi-Ud-Din; Reyaz Hassan Mir; Abdul Jalil Shah; Saba Sabreen; Taha Umair Wani; Mubashir Hussain Masoodi; Esra Küpeli Akkol; Zulfiqar Ali Bhat; Haroon Khan
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.